insights_auto
Why is MBRX up 4.32%?
Dive Deeperchevron_right
MBRX:NASDAQ
Moleculin Biotech Inc
$0.59
arrow_upward
+4.32%(+0.024) 1D
Sep 23, 9:46:29 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBRX...
Open
$0.58
High
$0.61
Low
$0.57
Mkt. cap
11.58M
Avg. vol.
1.02M
Volume
626.03K
52-wk high
$15.75
52-wk low
$0.16
EPS
-$15.07
Beta
1.92
Shares outstanding
19.48M
No. of employees
17
Open
$0.58
High
$0.61
Low
$0.57
Mkt. cap
11.58M
Avg. vol.
1.02M
Volume
626.03K
52-wk high
$15.75
52-wk low
$0.16
EPS
-$15.07
Beta
1.92
Shares outstanding
19.48M
No. of employees
17
News stories
From web sources and news partners
TipRanks
·
28 minutes ago
Moleculin Secures Mexican Patent Strengthening Annamycin IP Portfolio
Investing.com
·
31 minutes ago
Moleculin receives Mexican patent for Annamycin formulation
Investing.com Canada
·
48 minutes ago
Form 8K Moleculin Biotech Inc For: 23 September By Investing.com
Stock Titan
·
1 hour ago
Moleculin (NASDAQ: MBRX) lowers warrant price while stating it needs trial funding
About Moleculin Biotech Inc
CEO-
Employees17
Founded2015
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitemoleculin.com